开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2167926, encodeId=fe30216e926e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞分子 经验分享：WB必须要全膜图片被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf559026248, createdName=ms5000001689279526, createdTime=Fri Nov 10 23:17:56 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145668, encodeId=6ec0214566804, content=需要提交全膜的WB原图，我的WB剪开孵了不同的抗体，我merge上marker把剪开的一张膜不同抗体拼成全膜都说不符合要求，就3分杂志真是离了大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=lichichi1949, createdTime=Fri Jun 30 15:34:04 CST 2023, time=2023-06-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2118345, encodeId=064b211834595, content=审稿很快，我修改花的时间比较多，12月14投稿，1月7号收到大修通知，给了4个月的修改时间，2月27修会，3月8号收到邮件接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3b38147708, createdName=ms1000001579851578, createdTime=Wed Mar 08 21:59:21 CST 2023, time=2023-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107061, encodeId=5f1c210e06183, content=你们有碰到说找不到审稿人的撤稿原因吗？要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5d5486828, createdName=shahsa, createdTime=Thu Dec 22 14:28:34 CST 2022, time=2022-12-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=804695, encodeId=d44780469508, content=怎么知道外没外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Mon Jul 27 09:00:39 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112831, encodeId=5eda2112831b8, content=这个期刊近一两年发文量骤减，是要停办了吗？有最近投稿的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/2acde58eed6d45dc9844b8946a55f6df/719584dda5654f398cb6e98723436e71.jpg, createdBy=a6415428895, createdName=Desmond_MS, createdTime=Fri Feb 03 02:50:57 CST 2023, time=2023-02-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230309, encodeId=68cf12303096d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：自噬;缺血;神经 经验分享：一审5周，两个审稿人一个拒，一个大修，编辑提了几个问题。二审4周，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de576144666, createdName=ms5000001807251989, createdTime=Sun Jul 03 16:47:33 CST 2022, time=2022-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099991, encodeId=984e209999185, content=想问一下大家，投稿窗口在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da3b5443317, createdName=ms5000001300554731, createdTime=Fri Nov 11 22:31:30 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584322, encodeId=fcf9584322fe, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：我是1月12投的文章，当天通知格式不正确后，马上调整重新投过去，三个星期后2.2一修意见过来，2.4修回，2.6通知接受，从投到接受不到一个月，感觉分一直在涨，最关键就是快，适合毕业季投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab12173447, createdName=CRthoracic, createdTime=Thu Feb 06 16:23:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242141, encodeId=72bf124214107, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：遗传学 经验分享：投的遗传学稿件，审稿速度很快，8月18号投稿，第二天提示修改格式，8月25号收到小修的通知，今天刚刚提交修稿，希望一切顺利，希望修回也和审稿一样快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Tue Aug 30 22:08:04 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2023-11-10 ms5000001689279526 来自山东省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：细胞分子
经验分享：WB必须要全膜图片被拒

69 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167926, encodeId=fe30216e926e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞分子 经验分享：WB必须要全膜图片被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf559026248, createdName=ms5000001689279526, createdTime=Fri Nov 10 23:17:56 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145668, encodeId=6ec0214566804, content=需要提交全膜的WB原图，我的WB剪开孵了不同的抗体，我merge上marker把剪开的一张膜不同抗体拼成全膜都说不符合要求，就3分杂志真是离了大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=lichichi1949, createdTime=Fri Jun 30 15:34:04 CST 2023, time=2023-06-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2118345, encodeId=064b211834595, content=审稿很快，我修改花的时间比较多，12月14投稿，1月7号收到大修通知，给了4个月的修改时间，2月27修会，3月8号收到邮件接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3b38147708, createdName=ms1000001579851578, createdTime=Wed Mar 08 21:59:21 CST 2023, time=2023-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107061, encodeId=5f1c210e06183, content=你们有碰到说找不到审稿人的撤稿原因吗？要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5d5486828, createdName=shahsa, createdTime=Thu Dec 22 14:28:34 CST 2022, time=2022-12-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=804695, encodeId=d44780469508, content=怎么知道外没外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Mon Jul 27 09:00:39 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112831, encodeId=5eda2112831b8, content=这个期刊近一两年发文量骤减，是要停办了吗？有最近投稿的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/2acde58eed6d45dc9844b8946a55f6df/719584dda5654f398cb6e98723436e71.jpg, createdBy=a6415428895, createdName=Desmond_MS, createdTime=Fri Feb 03 02:50:57 CST 2023, time=2023-02-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230309, encodeId=68cf12303096d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：自噬;缺血;神经 经验分享：一审5周，两个审稿人一个拒，一个大修，编辑提了几个问题。二审4周，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de576144666, createdName=ms5000001807251989, createdTime=Sun Jul 03 16:47:33 CST 2022, time=2022-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099991, encodeId=984e209999185, content=想问一下大家，投稿窗口在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da3b5443317, createdName=ms5000001300554731, createdTime=Fri Nov 11 22:31:30 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584322, encodeId=fcf9584322fe, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：我是1月12投的文章，当天通知格式不正确后，马上调整重新投过去，三个星期后2.2一修意见过来，2.4修回，2.6通知接受，从投到接受不到一个月，感觉分一直在涨，最关键就是快，适合毕业季投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab12173447, createdName=CRthoracic, createdTime=Thu Feb 06 16:23:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242141, encodeId=72bf124214107, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：遗传学 经验分享：投的遗传学稿件，审稿速度很快，8月18号投稿，第二天提示修改格式，8月25号收到小修的通知，今天刚刚提交修稿，希望一切顺利，希望修回也和审稿一样快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Tue Aug 30 22:08:04 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2023-06-30 lichichi1949 来自四川省

需要提交全膜的WB原图，我的WB剪开孵了不同的抗体，我merge上marker把剪开的一张膜不同抗体拼成全膜都说不符合要求，就3分杂志真是离了大谱

81 0

[GetPortalCommentsPageByObjectIdResponse(id=2167926, encodeId=fe30216e926e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞分子 经验分享：WB必须要全膜图片被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf559026248, createdName=ms5000001689279526, createdTime=Fri Nov 10 23:17:56 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145668, encodeId=6ec0214566804, content=需要提交全膜的WB原图，我的WB剪开孵了不同的抗体，我merge上marker把剪开的一张膜不同抗体拼成全膜都说不符合要求，就3分杂志真是离了大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=lichichi1949, createdTime=Fri Jun 30 15:34:04 CST 2023, time=2023-06-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2118345, encodeId=064b211834595, content=审稿很快，我修改花的时间比较多，12月14投稿，1月7号收到大修通知，给了4个月的修改时间，2月27修会，3月8号收到邮件接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3b38147708, createdName=ms1000001579851578, createdTime=Wed Mar 08 21:59:21 CST 2023, time=2023-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107061, encodeId=5f1c210e06183, content=你们有碰到说找不到审稿人的撤稿原因吗？要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5d5486828, createdName=shahsa, createdTime=Thu Dec 22 14:28:34 CST 2022, time=2022-12-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=804695, encodeId=d44780469508, content=怎么知道外没外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Mon Jul 27 09:00:39 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112831, encodeId=5eda2112831b8, content=这个期刊近一两年发文量骤减，是要停办了吗？有最近投稿的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/2acde58eed6d45dc9844b8946a55f6df/719584dda5654f398cb6e98723436e71.jpg, createdBy=a6415428895, createdName=Desmond_MS, createdTime=Fri Feb 03 02:50:57 CST 2023, time=2023-02-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230309, encodeId=68cf12303096d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：自噬;缺血;神经 经验分享：一审5周，两个审稿人一个拒，一个大修，编辑提了几个问题。二审4周，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de576144666, createdName=ms5000001807251989, createdTime=Sun Jul 03 16:47:33 CST 2022, time=2022-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099991, encodeId=984e209999185, content=想问一下大家，投稿窗口在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da3b5443317, createdName=ms5000001300554731, createdTime=Fri Nov 11 22:31:30 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584322, encodeId=fcf9584322fe, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：我是1月12投的文章，当天通知格式不正确后，马上调整重新投过去，三个星期后2.2一修意见过来，2.4修回，2.6通知接受，从投到接受不到一个月，感觉分一直在涨，最关键就是快，适合毕业季投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab12173447, createdName=CRthoracic, createdTime=Thu Feb 06 16:23:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242141, encodeId=72bf124214107, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：遗传学 经验分享：投的遗传学稿件，审稿速度很快，8月18号投稿，第二天提示修改格式，8月25号收到小修的通知，今天刚刚提交修稿，希望一切顺利，希望修回也和审稿一样快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Tue Aug 30 22:08:04 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2023-03-08 ms1000001579851578

审稿很快，我修改花的时间比较多，12月14投稿，1月7号收到大修通知，给了4个月的修改时间，2月27修会，3月8号收到邮件接受

87 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167926, encodeId=fe30216e926e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞分子 经验分享：WB必须要全膜图片被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf559026248, createdName=ms5000001689279526, createdTime=Fri Nov 10 23:17:56 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145668, encodeId=6ec0214566804, content=需要提交全膜的WB原图，我的WB剪开孵了不同的抗体，我merge上marker把剪开的一张膜不同抗体拼成全膜都说不符合要求，就3分杂志真是离了大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=lichichi1949, createdTime=Fri Jun 30 15:34:04 CST 2023, time=2023-06-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2118345, encodeId=064b211834595, content=审稿很快，我修改花的时间比较多，12月14投稿，1月7号收到大修通知，给了4个月的修改时间，2月27修会，3月8号收到邮件接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3b38147708, createdName=ms1000001579851578, createdTime=Wed Mar 08 21:59:21 CST 2023, time=2023-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107061, encodeId=5f1c210e06183, content=你们有碰到说找不到审稿人的撤稿原因吗？要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5d5486828, createdName=shahsa, createdTime=Thu Dec 22 14:28:34 CST 2022, time=2022-12-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=804695, encodeId=d44780469508, content=怎么知道外没外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Mon Jul 27 09:00:39 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112831, encodeId=5eda2112831b8, content=这个期刊近一两年发文量骤减，是要停办了吗？有最近投稿的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/2acde58eed6d45dc9844b8946a55f6df/719584dda5654f398cb6e98723436e71.jpg, createdBy=a6415428895, createdName=Desmond_MS, createdTime=Fri Feb 03 02:50:57 CST 2023, time=2023-02-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230309, encodeId=68cf12303096d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：自噬;缺血;神经 经验分享：一审5周，两个审稿人一个拒，一个大修，编辑提了几个问题。二审4周，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de576144666, createdName=ms5000001807251989, createdTime=Sun Jul 03 16:47:33 CST 2022, time=2022-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099991, encodeId=984e209999185, content=想问一下大家，投稿窗口在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da3b5443317, createdName=ms5000001300554731, createdTime=Fri Nov 11 22:31:30 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584322, encodeId=fcf9584322fe, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：我是1月12投的文章，当天通知格式不正确后，马上调整重新投过去，三个星期后2.2一修意见过来，2.4修回，2.6通知接受，从投到接受不到一个月，感觉分一直在涨，最关键就是快，适合毕业季投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab12173447, createdName=CRthoracic, createdTime=Thu Feb 06 16:23:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242141, encodeId=72bf124214107, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：遗传学 经验分享：投的遗传学稿件，审稿速度很快，8月18号投稿，第二天提示修改格式，8月25号收到小修的通知，今天刚刚提交修稿，希望一切顺利，希望修回也和审稿一样快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Tue Aug 30 22:08:04 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2022-12-22 shahsa 来自安徽省

你们有碰到说找不到审稿人的撤稿原因吗？要哭了

104 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167926, encodeId=fe30216e926e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞分子 经验分享：WB必须要全膜图片被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf559026248, createdName=ms5000001689279526, createdTime=Fri Nov 10 23:17:56 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145668, encodeId=6ec0214566804, content=需要提交全膜的WB原图，我的WB剪开孵了不同的抗体，我merge上marker把剪开的一张膜不同抗体拼成全膜都说不符合要求，就3分杂志真是离了大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=lichichi1949, createdTime=Fri Jun 30 15:34:04 CST 2023, time=2023-06-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2118345, encodeId=064b211834595, content=审稿很快，我修改花的时间比较多，12月14投稿，1月7号收到大修通知，给了4个月的修改时间，2月27修会，3月8号收到邮件接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3b38147708, createdName=ms1000001579851578, createdTime=Wed Mar 08 21:59:21 CST 2023, time=2023-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107061, encodeId=5f1c210e06183, content=你们有碰到说找不到审稿人的撤稿原因吗？要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5d5486828, createdName=shahsa, createdTime=Thu Dec 22 14:28:34 CST 2022, time=2022-12-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=804695, encodeId=d44780469508, content=怎么知道外没外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Mon Jul 27 09:00:39 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112831, encodeId=5eda2112831b8, content=这个期刊近一两年发文量骤减，是要停办了吗？有最近投稿的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/2acde58eed6d45dc9844b8946a55f6df/719584dda5654f398cb6e98723436e71.jpg, createdBy=a6415428895, createdName=Desmond_MS, createdTime=Fri Feb 03 02:50:57 CST 2023, time=2023-02-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230309, encodeId=68cf12303096d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：自噬;缺血;神经 经验分享：一审5周，两个审稿人一个拒，一个大修，编辑提了几个问题。二审4周，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de576144666, createdName=ms5000001807251989, createdTime=Sun Jul 03 16:47:33 CST 2022, time=2022-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099991, encodeId=984e209999185, content=想问一下大家，投稿窗口在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da3b5443317, createdName=ms5000001300554731, createdTime=Fri Nov 11 22:31:30 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584322, encodeId=fcf9584322fe, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：我是1月12投的文章，当天通知格式不正确后，马上调整重新投过去，三个星期后2.2一修意见过来，2.4修回，2.6通知接受，从投到接受不到一个月，感觉分一直在涨，最关键就是快，适合毕业季投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab12173447, createdName=CRthoracic, createdTime=Thu Feb 06 16:23:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242141, encodeId=72bf124214107, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：遗传学 经验分享：投的遗传学稿件，审稿速度很快，8月18号投稿，第二天提示修改格式，8月25号收到小修的通知，今天刚刚提交修稿，希望一切顺利，希望修回也和审稿一样快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Tue Aug 30 22:08:04 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2020-07-27 145d9400m83暂无昵称

怎么知道外没外审？

274 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167926, encodeId=fe30216e926e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞分子 经验分享：WB必须要全膜图片被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf559026248, createdName=ms5000001689279526, createdTime=Fri Nov 10 23:17:56 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145668, encodeId=6ec0214566804, content=需要提交全膜的WB原图，我的WB剪开孵了不同的抗体，我merge上marker把剪开的一张膜不同抗体拼成全膜都说不符合要求，就3分杂志真是离了大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=lichichi1949, createdTime=Fri Jun 30 15:34:04 CST 2023, time=2023-06-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2118345, encodeId=064b211834595, content=审稿很快，我修改花的时间比较多，12月14投稿，1月7号收到大修通知，给了4个月的修改时间，2月27修会，3月8号收到邮件接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3b38147708, createdName=ms1000001579851578, createdTime=Wed Mar 08 21:59:21 CST 2023, time=2023-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107061, encodeId=5f1c210e06183, content=你们有碰到说找不到审稿人的撤稿原因吗？要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5d5486828, createdName=shahsa, createdTime=Thu Dec 22 14:28:34 CST 2022, time=2022-12-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=804695, encodeId=d44780469508, content=怎么知道外没外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Mon Jul 27 09:00:39 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112831, encodeId=5eda2112831b8, content=这个期刊近一两年发文量骤减，是要停办了吗？有最近投稿的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/2acde58eed6d45dc9844b8946a55f6df/719584dda5654f398cb6e98723436e71.jpg, createdBy=a6415428895, createdName=Desmond_MS, createdTime=Fri Feb 03 02:50:57 CST 2023, time=2023-02-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230309, encodeId=68cf12303096d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：自噬;缺血;神经 经验分享：一审5周，两个审稿人一个拒，一个大修，编辑提了几个问题。二审4周，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de576144666, createdName=ms5000001807251989, createdTime=Sun Jul 03 16:47:33 CST 2022, time=2022-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099991, encodeId=984e209999185, content=想问一下大家，投稿窗口在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da3b5443317, createdName=ms5000001300554731, createdTime=Fri Nov 11 22:31:30 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584322, encodeId=fcf9584322fe, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：我是1月12投的文章，当天通知格式不正确后，马上调整重新投过去，三个星期后2.2一修意见过来，2.4修回，2.6通知接受，从投到接受不到一个月，感觉分一直在涨，最关键就是快，适合毕业季投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab12173447, createdName=CRthoracic, createdTime=Thu Feb 06 16:23:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242141, encodeId=72bf124214107, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：遗传学 经验分享：投的遗传学稿件，审稿速度很快，8月18号投稿，第二天提示修改格式，8月25号收到小修的通知，今天刚刚提交修稿，希望一切顺利，希望修回也和审稿一样快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Tue Aug 30 22:08:04 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2023-02-03 Desmond_MS 来自重庆

这个期刊近一两年发文量骤减，是要停办了吗？有最近投稿的吗？

82 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167926, encodeId=fe30216e926e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞分子 经验分享：WB必须要全膜图片被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf559026248, createdName=ms5000001689279526, createdTime=Fri Nov 10 23:17:56 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145668, encodeId=6ec0214566804, content=需要提交全膜的WB原图，我的WB剪开孵了不同的抗体，我merge上marker把剪开的一张膜不同抗体拼成全膜都说不符合要求，就3分杂志真是离了大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=lichichi1949, createdTime=Fri Jun 30 15:34:04 CST 2023, time=2023-06-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2118345, encodeId=064b211834595, content=审稿很快，我修改花的时间比较多，12月14投稿，1月7号收到大修通知，给了4个月的修改时间，2月27修会，3月8号收到邮件接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3b38147708, createdName=ms1000001579851578, createdTime=Wed Mar 08 21:59:21 CST 2023, time=2023-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107061, encodeId=5f1c210e06183, content=你们有碰到说找不到审稿人的撤稿原因吗？要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5d5486828, createdName=shahsa, createdTime=Thu Dec 22 14:28:34 CST 2022, time=2022-12-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=804695, encodeId=d44780469508, content=怎么知道外没外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Mon Jul 27 09:00:39 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112831, encodeId=5eda2112831b8, content=这个期刊近一两年发文量骤减，是要停办了吗？有最近投稿的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/2acde58eed6d45dc9844b8946a55f6df/719584dda5654f398cb6e98723436e71.jpg, createdBy=a6415428895, createdName=Desmond_MS, createdTime=Fri Feb 03 02:50:57 CST 2023, time=2023-02-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230309, encodeId=68cf12303096d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：自噬;缺血;神经 经验分享：一审5周，两个审稿人一个拒，一个大修，编辑提了几个问题。二审4周，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de576144666, createdName=ms5000001807251989, createdTime=Sun Jul 03 16:47:33 CST 2022, time=2022-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099991, encodeId=984e209999185, content=想问一下大家，投稿窗口在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da3b5443317, createdName=ms5000001300554731, createdTime=Fri Nov 11 22:31:30 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584322, encodeId=fcf9584322fe, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：我是1月12投的文章，当天通知格式不正确后，马上调整重新投过去，三个星期后2.2一修意见过来，2.4修回，2.6通知接受，从投到接受不到一个月，感觉分一直在涨，最关键就是快，适合毕业季投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab12173447, createdName=CRthoracic, createdTime=Thu Feb 06 16:23:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242141, encodeId=72bf124214107, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：遗传学 经验分享：投的遗传学稿件，审稿速度很快，8月18号投稿，第二天提示修改格式，8月25号收到小修的通知，今天刚刚提交修稿，希望一切顺利，希望修回也和审稿一样快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Tue Aug 30 22:08:04 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2022-07-03 ms5000001807251989

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：自噬;缺血;神经
经验分享：一审5周，两个审稿人一个拒，一个大修，编辑提了几个问题。二审4周，接收。

92 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167926, encodeId=fe30216e926e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞分子 经验分享：WB必须要全膜图片被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf559026248, createdName=ms5000001689279526, createdTime=Fri Nov 10 23:17:56 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145668, encodeId=6ec0214566804, content=需要提交全膜的WB原图，我的WB剪开孵了不同的抗体，我merge上marker把剪开的一张膜不同抗体拼成全膜都说不符合要求，就3分杂志真是离了大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=lichichi1949, createdTime=Fri Jun 30 15:34:04 CST 2023, time=2023-06-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2118345, encodeId=064b211834595, content=审稿很快，我修改花的时间比较多，12月14投稿，1月7号收到大修通知，给了4个月的修改时间，2月27修会，3月8号收到邮件接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3b38147708, createdName=ms1000001579851578, createdTime=Wed Mar 08 21:59:21 CST 2023, time=2023-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107061, encodeId=5f1c210e06183, content=你们有碰到说找不到审稿人的撤稿原因吗？要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5d5486828, createdName=shahsa, createdTime=Thu Dec 22 14:28:34 CST 2022, time=2022-12-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=804695, encodeId=d44780469508, content=怎么知道外没外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Mon Jul 27 09:00:39 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112831, encodeId=5eda2112831b8, content=这个期刊近一两年发文量骤减，是要停办了吗？有最近投稿的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/2acde58eed6d45dc9844b8946a55f6df/719584dda5654f398cb6e98723436e71.jpg, createdBy=a6415428895, createdName=Desmond_MS, createdTime=Fri Feb 03 02:50:57 CST 2023, time=2023-02-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230309, encodeId=68cf12303096d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：自噬;缺血;神经 经验分享：一审5周，两个审稿人一个拒，一个大修，编辑提了几个问题。二审4周，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de576144666, createdName=ms5000001807251989, createdTime=Sun Jul 03 16:47:33 CST 2022, time=2022-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099991, encodeId=984e209999185, content=想问一下大家，投稿窗口在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da3b5443317, createdName=ms5000001300554731, createdTime=Fri Nov 11 22:31:30 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584322, encodeId=fcf9584322fe, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：我是1月12投的文章，当天通知格式不正确后，马上调整重新投过去，三个星期后2.2一修意见过来，2.4修回，2.6通知接受，从投到接受不到一个月，感觉分一直在涨，最关键就是快，适合毕业季投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab12173447, createdName=CRthoracic, createdTime=Thu Feb 06 16:23:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242141, encodeId=72bf124214107, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：遗传学 经验分享：投的遗传学稿件，审稿速度很快，8月18号投稿，第二天提示修改格式，8月25号收到小修的通知，今天刚刚提交修稿，希望一切顺利，希望修回也和审稿一样快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Tue Aug 30 22:08:04 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2022-11-11 ms5000001300554731

想问一下大家，投稿窗口在哪里

91 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167926, encodeId=fe30216e926e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞分子 经验分享：WB必须要全膜图片被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf559026248, createdName=ms5000001689279526, createdTime=Fri Nov 10 23:17:56 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145668, encodeId=6ec0214566804, content=需要提交全膜的WB原图，我的WB剪开孵了不同的抗体，我merge上marker把剪开的一张膜不同抗体拼成全膜都说不符合要求，就3分杂志真是离了大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=lichichi1949, createdTime=Fri Jun 30 15:34:04 CST 2023, time=2023-06-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2118345, encodeId=064b211834595, content=审稿很快，我修改花的时间比较多，12月14投稿，1月7号收到大修通知，给了4个月的修改时间，2月27修会，3月8号收到邮件接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3b38147708, createdName=ms1000001579851578, createdTime=Wed Mar 08 21:59:21 CST 2023, time=2023-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107061, encodeId=5f1c210e06183, content=你们有碰到说找不到审稿人的撤稿原因吗？要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5d5486828, createdName=shahsa, createdTime=Thu Dec 22 14:28:34 CST 2022, time=2022-12-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=804695, encodeId=d44780469508, content=怎么知道外没外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Mon Jul 27 09:00:39 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112831, encodeId=5eda2112831b8, content=这个期刊近一两年发文量骤减，是要停办了吗？有最近投稿的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/2acde58eed6d45dc9844b8946a55f6df/719584dda5654f398cb6e98723436e71.jpg, createdBy=a6415428895, createdName=Desmond_MS, createdTime=Fri Feb 03 02:50:57 CST 2023, time=2023-02-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230309, encodeId=68cf12303096d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：自噬;缺血;神经 经验分享：一审5周，两个审稿人一个拒，一个大修，编辑提了几个问题。二审4周，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de576144666, createdName=ms5000001807251989, createdTime=Sun Jul 03 16:47:33 CST 2022, time=2022-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099991, encodeId=984e209999185, content=想问一下大家，投稿窗口在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da3b5443317, createdName=ms5000001300554731, createdTime=Fri Nov 11 22:31:30 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584322, encodeId=fcf9584322fe, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：我是1月12投的文章，当天通知格式不正确后，马上调整重新投过去，三个星期后2.2一修意见过来，2.4修回，2.6通知接受，从投到接受不到一个月，感觉分一直在涨，最关键就是快，适合毕业季投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab12173447, createdName=CRthoracic, createdTime=Thu Feb 06 16:23:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242141, encodeId=72bf124214107, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：遗传学 经验分享：投的遗传学稿件，审稿速度很快，8月18号投稿，第二天提示修改格式，8月25号收到小修的通知，今天刚刚提交修稿，希望一切顺利，希望修回也和审稿一样快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Tue Aug 30 22:08:04 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2020-02-06 CRthoracic

审稿速度:1.0 | 投稿命中率:75.0
经验分享：我是1月12投的文章，当天通知格式不正确后，马上调整重新投过去，三个星期后2.2一修意见过来，2.4修回，2.6通知接受，从投到接受不到一个月，感觉分一直在涨，最关键就是快，适合毕业季投稿！

183 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2167926, encodeId=fe30216e926e5, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞分子 经验分享：WB必须要全膜图片被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf559026248, createdName=ms5000001689279526, createdTime=Fri Nov 10 23:17:56 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145668, encodeId=6ec0214566804, content=需要提交全膜的WB原图，我的WB剪开孵了不同的抗体，我merge上marker把剪开的一张膜不同抗体拼成全膜都说不符合要求，就3分杂志真是离了大谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=lichichi1949, createdTime=Fri Jun 30 15:34:04 CST 2023, time=2023-06-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2118345, encodeId=064b211834595, content=审稿很快，我修改花的时间比较多，12月14投稿，1月7号收到大修通知，给了4个月的修改时间，2月27修会，3月8号收到邮件接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3b38147708, createdName=ms1000001579851578, createdTime=Wed Mar 08 21:59:21 CST 2023, time=2023-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107061, encodeId=5f1c210e06183, content=你们有碰到说找不到审稿人的撤稿原因吗？要哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff5d5486828, createdName=shahsa, createdTime=Thu Dec 22 14:28:34 CST 2022, time=2022-12-22, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=804695, encodeId=d44780469508, content=怎么知道外没外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24355093072, createdName=145d9400m83暂无昵称, createdTime=Mon Jul 27 09:00:39 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112831, encodeId=5eda2112831b8, content=这个期刊近一两年发文量骤减，是要停办了吗？有最近投稿的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/2acde58eed6d45dc9844b8946a55f6df/719584dda5654f398cb6e98723436e71.jpg, createdBy=a6415428895, createdName=Desmond_MS, createdTime=Fri Feb 03 02:50:57 CST 2023, time=2023-02-03, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1230309, encodeId=68cf12303096d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：自噬;缺血;神经 经验分享：一审5周，两个审稿人一个拒，一个大修，编辑提了几个问题。二审4周，接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de576144666, createdName=ms5000001807251989, createdTime=Sun Jul 03 16:47:33 CST 2022, time=2022-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099991, encodeId=984e209999185, content=想问一下大家，投稿窗口在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da3b5443317, createdName=ms5000001300554731, createdTime=Fri Nov 11 22:31:30 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584322, encodeId=fcf9584322fe, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：我是1月12投的文章，当天通知格式不正确后，马上调整重新投过去，三个星期后2.2一修意见过来，2.4修回，2.6通知接受，从投到接受不到一个月，感觉分一直在涨，最关键就是快，适合毕业季投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab12173447, createdName=CRthoracic, createdTime=Thu Feb 06 16:23:00 CST 2020, time=2020-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242141, encodeId=72bf124214107, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：遗传学 经验分享：投的遗传学稿件，审稿速度很快，8月18号投稿，第二天提示修改格式，8月25号收到小修的通知，今天刚刚提交修稿，希望一切顺利，希望修回也和审稿一样快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3a22547456, createdName=99237898_40722890, createdTime=Tue Aug 30 22:08:04 CST 2022, time=2022-08-30, status=1, ipAttribution=)]

2022-08-30 99237898_40722890

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：遗传学
经验分享：投的遗传学稿件，审稿速度很快，8月18号投稿，第二天提示修改格式，8月25号收到小修的通知，今天刚刚提交修稿，希望一切顺利，希望修回也和审稿一样快

97 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务